Abstract
We agree with Blumer’s (1) contention that patients with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) therapy represent a well-motivated patient population. In this context, he asks whether differences in patient motivation (as reflected in adherence to frequent self-monitoring of blood glucose and regular contact with diabetes educators) may underlie the finding of improved glycemic control with CSII as compared with multiple daily insulin injection (MDII) therapy in our recent pooled analysis …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
